Agoracom Blog Home

Posts Tagged ‘small cap stocks’

TransCanna $TCAN.ca and Award-Winning Product Producers, the Summit Boys, to Co-Brand #Cannabis Concentrates $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:11 AM on Tuesday, July 21st, 2020
tcan-square
  • Announced a Memorandum of Understanding with award-winning and leading legacy cannabis brand, the Summit Boys, to co-brand a series of high-quality cannabis concentrates
  • Summit Boys are a well-known legacy recreational cannabis product producers (operating since 2016 under prop 215 and with a cult-like following on Instagram of over 66,000 followers).
  • Demand for Cannabis Concentrates are the Fastest Growing of all Related Product Categories

Vancouver, British Columbia–(July 21, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce a Memorandum of Understanding with award-winning and leading legacy cannabis brand, the Summit Boys, to co-brand a series of high-quality cannabis concentrates.

The Summit Boys are a well-known legacy recreational cannabis product producers (operating since 2016 under prop 215 and with a cult-like following on Instagram of over 66,000 followers). In this agreement, Lyfted Farms (a TransCanna subsidiary), will supply high-quality cannabis flower to the Summit Boys for processing into a line of popular cannabis concentrates branded as ‘Caviar.’

In 2019, the Summit Boys earned 14 awards in the Bay Area Cannabis Cup in several categories, including for Best Product and Hybrid Concentrate for this same Caviar product. The line of ‘White Caviar’ branded products are what The Summit Boys are best known for.

Cannabis concentrates have a greater proportion of cannabinoids and terpenes when compared to natural cannabis flowers, and can increase the potency of cannabis flower. Demand for these concentrates are also the fastest-growing of any cannabis product in the California market (the largest Cannabis market globally).

“This co-branding of the already famous Caviar product now powered by Lyfted’s flower is great news for cannabis consumers,” says Bob Blink, TransCanna CEO. “For us, it’s another example of our strategy to align with high-quality producers and already successful players in the industry-this time with the added value of the Summit Boys’ grassroots following. But for the more sophisticated California cannabis market, this partnership will mean an even higher quality product for consumers.”

“As a dedicated brand to California Cannabis market, we wanted to find like-minded partners. Since meeting the Lyfted team, they have earned our respect, and we definitely look forward to working together. There are many things that excite us, but being able to co-brand and scale now that the Daly Facility is licensed is a huge opportunity, ” stated Mike Larson, Summit Boys CEO.

News of this agreement follows an announcement by TransCanna that the Company was awarded its final operating license for the 196,000 square foot Daly Facility by the California Bureau of Cannabis Control July 10, 2020.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors,

Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as “forward-looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California, as and when expected.

These forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward-looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth;; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.

TransCanna $TCAN.ca Commences “Phase 1” Construction and Roll-Out of Commercial Activities at Flagship Daly Facility $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:01 AM on Thursday, July 16th, 2020
tcan-square
  • Begun preparations for the commercial launch of distribution activities at its flagship 196,000 square foot Daly Avenue Facility in Modesto California
  • Goal of Phase 1 is to focus on expansion and ramp-up of the companies’ distribution activities
  • Revised design of Phase 1 of the Daly Distribution build-out increases capacity by 16,000 square feet, allowing the Company to expand this core business unit to service escalating demand from customers

Vancouver, British Columbia–(July 16, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (“TransCanna” or the “Company”) is pleased to announce that with the recent state-wide final license approval, today its wholly-owned subsidiary, Lyfted Farms, Inc. (“Lyfted”), has begun preparations for the commercial launch of distribution activities at its flagship 196,000 square foot Daly Avenue Facility in Modesto California.

The goal of Phase 1 is to focus on expansion and ramp-up of the companies’ distribution activities. The revised design of Phase 1 of the Daly Distribution build-out increases capacity by 16,000 square feet, allowing the Company to expand this core business unit to service escalating demand from customers.

“After many months of planning and preparation, our team is thrilled to begin operations inside of Daly,” said CEO Bob Blink. “We look forward to rewarding our investors’ patience with this initial phase and present the true potential we believe The Daly Building has to offer. As early as Q4 2020, we expect to see an incremental increase in revenue from Distribution activities in the vicinity of $6,000,000 CDN per quarter. When combined with existing revenues, our target run-rate by our fiscal year-end should exceed previous projections and be in the neighborhood of $36,000,000 CDN.”

Lyfted Farms has accepted a contract with Bay Alarm Company to install a state of the art, integrated security system in preparation for commercial activity at the Daly facility. Pre-site preparations are underway, and system completion is expected by August 15, 2020.

Additionally, the facility’s triple-redundancy heating, ventilation, and air conditioning “HVAC,” sub-forty-degree Fahrenheit freezer, and distribution area systems have been activated for pre-cooling and calibration within the areas of operation. Employee technician training has started on the Company’s high speed automated packaging systems, combining WeighPack Swifty Baggers and Combiscale 14-head rotary scales to provide high-efficiency and precision filling, which reduce labor and material costs to industry-leading levels.

Packaging and support materials began arriving this week into the Daly distribution center with completion of the Phase 1 Distribution build-out expected by September 15, 2020.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board,

Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of the Company. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “anticipates”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “should”, “would” or “occur”. This information and these statements, referred to herein as “forward‐looking statements”, are not historical facts, are made as of the date of this news release and include without limitation estimates and forecasts and statements as to management’s expectations for growth and the commencement of operations of the Company’s Daly facility.

The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that operations will commence at the Company’s Daly facility in Modesto, California as and when expected.

These forward‐looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially from any future results, events or developments expressed or implied by such forward-looking statements. Risks and uncertainties associated with the forward looking information in this news release include, among others, dependence on obtaining and maintaining regulatory approvals, including state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete upgrades to its Daly facility in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth;; reliance on management; and the effect of capital market conditions and other factors (including those related to the COVID-19 pandemic) on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look, except in accordance with applicable securities laws.

CLIENT FEATURE: Binovi Technologies $VISN.ca Creating Faster Brains Through Stronger Eyes $EYPT $KALA

Posted by AGORACOM-JC at 6:00 PM on Wednesday, July 15th, 2020
http://www.smallcapepicenter.com/binovi%20square.png

Trusted and used by some of the world’s top professional sports teams, including:

(VISN:TSXV) (EYCCF:OTCQB) (2EYA:GR)

Binovi Technologies Secures VIMA Rev Strobe Lenses through a Strategic Product Acquisition

REV training enhances your sensory skills by removing milliseconds of visual information. Think of it like resistance training for your brain. As the REV lenses strobe, your brain is forced to work with less, making decisions and reacting in a hyper-efficient way.

  • Technology will seamlessly integrate into the Company’s Binovi Product Platform
  • Vision training stimulates “perceptual learning,” as it relates to the brain’s ability to improve perception through neuro-vision training
  • The intended result is to enhance the brain’s visual processing speed and accuracy through various exercises
  • These performance improvements represent fine tuning of existing processing skills

Why Binovi?

  • Binovi Has Already Started Commercializing Its Vision Therapy Platform
  • Clients Include: 
    • Dallas Stars (NHL)
    • Chicago Cubs (MLB)
    • Sporting KC (MLS)
    • Tennis Canada
    • Showcased During NFL Scouting Combine
  • Company’s Vision Therapy Products Used In:
    • Over 1,500 Practices
    • 20 Countries
  • Flagship “Binovi” Is State-Of-The-Art Platform
    • Measures 14 Key Vision Skills
    • Essential For Maximizing Brain Performance
    • Shipped Over 400 Binovi Units (April 2020)
    • Goal Is 2,500 Binovi Units (End Of 2020)
  • Signed Sports Vision Partnership With Eli Wilson Goaltending
    • World Leader In Goaltending Development
    • 600 Active Goaltending Camp Participants
    • 50,000 Global Aspiring Goaltenders
  • Binovi is now well positioned to further commercialize and capitalize on massive demand for Vision Therapy and Training For Athletes and Education

Binovi Technologies is an advertising client of AGORA Internet Relations Corp.

INTERVIEW: TransCanna $TCAN.ca License Creates One Of California’s Largest Fully Licensed Cannabis Facilities $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 8:12 PM on Sunday, July 12th, 2020
tcan-square

TransCanna Holdings (TCAN:CSE) is part of the New Cannabis Kids On The Block wave that investors are demanding after mega financed companies flopped last year.  TCAN, on the other hand, is delivering the following to investors: 

·  $2M CAD Revenue April 2020 

·  $24.6M CAD Revenue Run Rate solely from TransCanna test facility 

·  $90M Annual Revenue expected from first full year upon completion of 196,000 Sq Ft Daly facility Q3 2021 

·  Daly facility will be one of the largest cannabis facilities in California 

And today the story got even better, with TCAN announcing that its wholly-owned subsidiary was granted a “Type 11 Distributor License” by the California Bureau of Cannabis Control for its 196,000 square foot Daly Avenue Facility. 

HUGE BUSINESS IMPLICATIONS – TRANSCANNA POSITIONED TO BECOME PART OF NEW LEADERSHIP GROUP IN CANNABIS  

As a result, Trancanna now owns the largest known, fully licensed cannabis facility in California.  Given the fact TCAN is processing more than $USD 1,000,000/month in wholesale cannabis transactions out of a distribution space of just 1,000 square feet, the implications for Daly expanding to 196,000 square feet are HUGE in the areas of:  

  • Capacity 
  • Revenue
  • Reach
  • …. much more 

The first round of cannabis leaders disappointed investors and created significant value destruction in the space.  But like every new mega industry that goes through a catharsis stage, the next round of growth gives birth to the best and potentially biggest players for the long haul.

The next 24 – 36 months are going to be fun for TCAN.  How fun?  Watch this interview with CEO Bob Blink.

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.

CLIENT FEATURE: Binovi Technologies $VISN.ca Creating Faster Brains Through Stronger Eyes $EYPT $KALA

Posted by AGORACOM-JC at 4:00 PM on Monday, July 6th, 2020
http://www.smallcapepicenter.com/binovi%20square.png

Trusted and used by some of the world’s top professional sports teams, including:

Why Binovi?

  • Binovi Has Already Started Commercializing Its Vision Therapy Platform
  • Company’s Vision Therapy Products Used In:
    • Over 1,500 Practices
    • 20 Countries
  • Flagship “Binovi” Is State-Of-The-Art Platform
    • Measures 14 Key Vision Skills
    • Essential For Maximizing Brain Performance
    • Shipped Over 400 Binovi Units (April 2020)
    • Goal Is 2,500 Binovi Units (End Of 2020)
  • Signed Sports Vision Partnership With Eli Wilson Goaltending
    • World Leader In Goaltending Development
    • 600 Active Goaltending Camp Participants
    • 50,000 Global Aspiring Goaltenders
  • Binovi is now well positioned to further commercialize and capitalize on massive demand for Vision Therapy and Training For Athletes and Education

THE MARKET OPPORTUNITY

  • Vision Therapy captures 3% of a $36B Yearly Vision Market today
  • Vision Therapy will grow by 22% this year and account for 4% of the $39B Yearly Market by year end
  • Sights are set on disrupting the sports performance industry in 2020 while receiving engagement from leaders within the human performance – sport performance industry
  • The size of the sports performance market reached a value of nearly $488.5B in 2018, having grown at a compound annual growth rate (CAGR) of 4.3% since 2014
  • Expected to grow at a CAGR of 5.9% to nearly $614.1B by 2022

Binovi Explained

Binovi Technologies is an advertising client of AGORA Internet Relations Corp.

Digital Health #Mhealth Funding Shatters Funding Records Despite #COVID Economy – SPONSOR: CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 3:40 PM on Monday, July 6th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Digital Health Funding Shatters Funding Records Despite COVID Economy

  • Despite COVID-19, digital health funding shattered all previous venture capital funding records for the sector by raising $6.3 billion in the first half of the year (1H), according to Mercom Capital Group.
  • The Austin, TX-based firm reported that the digital health funding in 1H was 24% higher than the $5.1 billion the space raised in the first half of 2019, despite the pandemic disrupting the economy

By: Amanda Pedersen

Despite COVID-19, digital health funding shattered all previous venture capital funding records for the sector by raising $6.3 billion in the first half of the year (1H), according to Mercom Capital Group.

The Austin, TX-based firm reported that the digital health funding in 1H was 24% higher than the $5.1 billion the space raised in the first half of 2019, despite the pandemic disrupting the economy. Mercom Capital Group is previewewed this data in advance of its upcoming 1H Digital Health Funding and M&A Report, which is expected to be published July 13.

Interestingly enough, venture funding reached $2.8 billion during the second quarter of 2020, an 11% decrease year-over-year compared to $3.1 billion raised in Q2 2019. Healthcare practice-centric digital health companies received 34% of the funding in Q2 2020, raising $947 million in 56 deals, and consumer-centric digital health companies accounted for 66% of the funding, raising $1.8 billion in 105 deals.

“Adoption of digital health technologies and products have accelerated since the COVID-19 outbreak, which is reflected in the funding spike in the first half of the year. Telehealth hype has been backed by $2 billion in venture funding with no signs of slowing down,” said Raj Prabhu, CEO of Mercom Capital Group.

This confirms what MD+DI has previously reported regarding telemedicine trends that emerged during the early days of the pandemic.

Other categories that received significant funding during the second quarter include mHealth apps, analytics, wellness, and medical imaging, Mercom reported.

The top-funded digital health categories in 1H 2020 were: telehealth with $1.9 billion, followed by analytics with $826 million, mHealth apps with $794 million, clinical decision support with $545 million, healthcare service booking with $326, and wearable sensors with $321 million.

The top telehealth VC deals in 1H 2020 included: $194 million raised by Amwell (formerly American Well), $155 million raised by KRY, $144 million raised by Zhiyun Health, $100 million raised by Mindstrong, and $93 million raised by Virta Health. Telehealth funding was distributed in 85 companies during 1H 2020.

The top overall digital health VC deals in 1H 2020 included: $285 million raised by ClassPass, $250 million raised by Alto Pharmacy, $194 million raised by Amwell, $155 million raised by KRY, and $150 million raised by Concerto HealthAI. Digital Health funding was distributed in 27 different countries in 1H 2020.

Mercom Capital Group is a global communications and consulting firm that produces funding and market intelligence reports covering a variety of “cleantech” sectors.

Source: https://www.mddionline.com/digital-health/digital-health-funding-shatters-funding-records-despite-covid-economy

Eyecarrot $EYC.ca Announces Change of Name to Binovi Technologies Corp and the Postponement of Annual Financial Statements $EYPT $KALA

Posted by AGORACOM-JC at 12:38 PM on Monday, June 29th, 2020
http://www.smallcapepicenter.com/eyc%20square.png
  • Announced that its Board of Directors has approved a name change from Eyecarrot Innovations Corp. to Binovi Technologies Corp.
  • In connection with the name change, the Company’s trading symbol on the TSX Venture Exchange will be changed to ‘VISN’
  • It is expected that the name change will be effected on or about June 30, 2020 and the Company’s common shares will begin trading under the new name and symbol upon market open on Thursday July 2, 2020, subject to final approval by TSXV

June 29, 2020 – Toronto, New York – Eyecarrot Innovations Corp., (Eyecarrot) (TSXV:EYC) | (OTC:EYCCF) | (2EYA:GR) a leader is neuro-vision performance technology, announces that its Board of Directors has approved a name change from Eyecarrot Innovations Corp. to Binovi Technologies Corp. In connection with the name change, the Company’s trading symbol on the TSX Venture Exchange (“TSXV”) will be changed to ‘VISN’. It is expected that the name change will be effected on or about June 30, 2020 and the Company’s common shares will begin trading under the new name and symbol upon market open on Thursday July 2, 2020, subject to final approval by TSXV. The CUSIP number assigned to the Company’s shares following the name change is 09076N109 (ISIN: CA09076N1096). No action is required to be taken by shareholders with respect to the name change. Outstanding share and warrant certificates are not affected by the name change and do not need to be exchanged.

Postponement of Annual Financial Statements

The Company announces the postponement of filing its annual financial statements and management’s discussion and analysis (collectively the “Annual Statements”) for the year ended February 29, 2020 due to logistics and delays caused by the COVID-19 pandemic.

The Company is relying on exemptive relief granted by Canadian securities regulatory authorities that allows it to delay the filing of its Annual Statements required by sections 4.2 and 5.12(2) of National Instrument 51-102 due to be filed by June 29, 2020. In response to the coronavirus disease pandemic, securities regulatory authorities in Canada have granted a blanket exemption allowing issuers an additional 45 days to complete their regulatory filings.

Eyecarrot anticipates that its Annual Statements will be available for filing at its earliest opportunity, which is expected to occur on or before August 12, 2020. Until such time as the Annual Statements are filed, the Company’s management and insiders are subject to a trading blackout that reflects the principals contained in section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.

Other than as previously disclosed by the Company in news releases, there have been no material business developments since the date of the last interim financial statements filed on January 30, 2020, copies of which are available under the Company’s profile on SEDAR at www.sedar.com. The Company will be providing an update news release on the status of filing its February 29, 2020 audited financial statements and its May 30, 2020 first quarter unaudited financial statements by July 29, 2020.

AGORACOM Agreement

The Company announces that further to its news release dated April 28, 2020, it will make its first issuance of shares under its online marketing and awareness program with Agora Internet Relations Corp. (“AGORACOM”). Pursuant to this first tranche, the Company will issue 52,154 common shares of the Company at a deemed price of $0.26. AGORACOM’s program includes a “CEO Verified” Discussion Forum. The forum serves as the Company’s primary social media platform to interact with both shareholders and the broader investment community in a fully moderated environment.

The Eyecarrot HUB can be found at https://agoracom.com/ir/EyecarrotInnovations

For additional information on the Company, please visit https://www.eyecarrot.com/investors/

About Binovi by Eyecarrot

Eyecarrot Innovations Corp. is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

Terry Booth

Executive Chairman

Adam Cegielski

Founder | CEO

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.eyecarrot.com/investors/

Forward looking information

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations, and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Mary Meeker’s Fund Invests in India #Edtech Startup Byju’s – SPONSOR: BetterU Education Corp. $BTRU.ca $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 9:45 PM on Sunday, June 28th, 2020

SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. betterU / Ottolearn launch FREE COVID-19 mobile resource toolkit to fight the global crisis – Click here for more information.

Mary Meeker’s Fund Invests in India Edtech Startup Byju’s

  • Mary Meeker’s venture capital fund Bond Capital has backed online education startup Byju’s, marking its first investment in India.
  • The startup, which simplifies math and science concepts for K-12 students through games and videos, has seen tremendous growth over the past year

By: Saritha Rai, Bloomberg News

(Bloomberg) — Mary Meeker’s venture capital fund Bond Capital has backed online education startup Byju’s, marking its first investment in India.

The startup, which simplifies math and science concepts for K-12 students through games and videos, has seen tremendous growth over the past year. That has further accelerated with coronavirus lockdowns shutting schools and prompting parents, teachers and students to seek out online resources.

Byju’s has over 57 million registered students and more than 3.5 million paid subscribers, and has doubled revenues from 28 billion rupees ($370 million) in the last financial year.

Byju’s is “endorsed by millions of students” and is a clear leader in education technology, Meeker, a general partner at Bond, said in a funding announcement. Existing investors include Facebook founder Mark Zuckerberg’s Chan Zuckerberg Initiative and Sequoia Capital.

Source: https://www.bnnbloomberg.ca/mary-meeker-s-fund-invests-in-india-edtech-startup-byju-s-1.1456742

TransCanna $TCAN.ca Closes Non-Brokered Warrant Financing $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:04 PM on Thursday, June 25th, 2020
tcan-square
  • Issued 5,000,000 warrants in a non-brokered private placement at a price of $0.05 per warrant for gross proceeds of $250,000
  • There were no finders’ fees payable on this private placement

Vancouver, British Columbia–(June 25, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) has issued 5,000,000 warrants in a non-brokered private placement at a price of $0.05 per warrant for gross proceeds of $250,000. There were no finders’ fees payable on this private placement.

The private placement is subject to the approval of the Canadian Securities Exchange (“CSE”) and the securities will be subject to a four-month hold period under securities laws. The Company intends to use the net proceeds from the private placement for working capital purposes.

Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $1.00 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on is equal to or greater than $1.30 for a period of 20 consecutive trading days.

The Company did not file a material change report more than 21 days before the expected closing of the private placement as the details of the private placement and the participation therein by related parties of the company were not settled until shortly prior to closing and the company wished to close on an expedited basis for sound business reasons and in a time frame consistent with usual market practices for transactions of this nature.

The Company also announces that it has granted 100,000 stock options to a consultant. The stock options are exercisable for a period of 3 years at an exercise price of $1.00. The stock options are being granted pursuant to the terms of the Company’s stock option plan and are subject to regulatory approval.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed, company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

Bob Blink, CEO

604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF ANY SECURITIES DESCRIBED HEREIN

#Covid19 Impact on #Mhealth Applications Market is Estimated to Reach USD 100.2 billion by 2023 – SPONSOR: CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 5:42 PM on Thursday, June 25th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Covid19 Impact on mHealth Applications Market is Estimated to Reach USD 100.2 billion by 2023

  • As per Market Research Future (MRFR), the global mHealth applications market is expected to reach USD 100.2 billion from 2017 to 2023
  • Global mHealth applications market is primarily driven by the increasing adoption of advanced technologies in healthcare sector and the need to reduce long waiting periods for specialists to access healthcare facilities

mHealth is one of the most advanced and disruptive trends in the healthcare sector that has been expanding at an exceptional rate over the last few years. mHealth changes the way traditional medical practices take place and creates a path for the future of healthcare. mHealth helps to track and manage health-related practices by using technologies such as Bluetooth, mobile network (GSM/ GPRS/3G/4 G), and Wi-Fi. Data collected by mHealth devices, such as mobile phones, tablets, laptops, and tablets, help medical professionals, consumers, and other users.

mHealth Applications Market Dynamics

The global mHealth applications market is primarily driven by the increasing adoption of advanced technologies in healthcare sector and the need to reduce long waiting periods for specialists to access healthcare facilities. The availability of mobile applications for users is experiencing rapid growth, particularly in healthcare applications that help consumers manage their illnesses, well-being, and chronic conditions. This increased role of patients, coupled with the increasing importance of keeping up-to-date information about their own health decisions, has contributed to an increase in the global adoption of mHealth applications.

The healthcare industry has moved towards a value-based care model, with mHealth becoming a widespread trend due to the advent of technologies such as remote monitoring, electronic medical records, and other communication platforms. The rising prevalence of disorders such as diabetes, hypertension, cancer, and obesity, as well as raising awareness of wellness and other preventive measures among patients, are expected to fuel the growth of the mHealth application industry.

The introduction of wearable devices from Fitbit, Apple, and Xiaomi have a positive impact on the market. Market growth appears to be positive, with increasing investment in wearable technology start-ups. These start-ups focus on categories of mHealth, such as personal safety, women’s health, and hydration monitoring, which promise exciting market prospects.

mHealth Applications Market Segmentation

The global market for mHealth applications has been segmented based on type, which includes monitoring applications, education & awareness, healthcare management, diagnosis & treatment, wellness & prevention, and others. The monitoring application segment had the largest market share of approximately 53.8% in 2016.

mHealth Applications Market Regional Analysis

Region-wise,the global mHealth applications market has been segmented into Europe, North America, Asia Pacific, and Middle East & Africa.

In 2016, Europe had the highest market share of 31.7% in the global market for mHealth applications, taking into account the regional market scenario.

The Asia Pacific is the second-largest and fastest-growing market in the global market for mHealth applications. APAC is forecast to rise at 33.7% CAGR in 2017-2023. Many Asian countries are adopting digital health strategies to manage healthcare delivery and deliver better outcomes. For example, the Digital India program aims to improve IT services to empower healthcare professionals. These initiatives are expected to make the Asia Pacific the fastest-growing segment in the forecast period.

North America is one of the leaders in the field of mhealth and is only behind the APAC. North America is estimated to cross USD 28762.1 million by 2023.

The Middle East and Africa were valued at USD 1334.9 in 2016 and is expected to rise at a steady pace over the forecast period.

Source: https://www.medgadget.com/2020/06/covid19-impact-on-mhealth-applications-market-is-estimated-to-reach-usd-100-2-billion-by-2023-size-share-clinical-health-data-stress-management-advance-technology-global-growth-factors-and-demand.html